Across TCGA pan-cancer cohorts, ZRSR2P1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ZRSR2P1 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZRSR2P1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZRSR2P1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, STAD, and LUAD are the cancer types where ZRSR2P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.957	0.619	.014	28	view →
STAD	OS	Median	All	0.003	0.667	<.001	24	view →
LUAD	OS	Median	All	0.257	0.812	.003	12	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: ZRSR2P1 tumor-vs-normal RNA expression · all ZRSR2P1 data types